• Services
    • Overview
    • Autoantibody Biomarker Profiling
    • Oncology Drug Screening
    • Immunoprofiling
    • Vaccine Development
    • Custom Protein Arrays
  • Applications
        • Disease Area
          • Autoimmune Disease
          • Immuno-oncology
          • Neurological Disease
          • Infectious Disease
        • Application Area
          • Biomarker Discovery
          • Patient Stratification
          • Response & Adverse Event Prediction
          • Diagnostics & CDx Development
  • Technology
    • Overview
    • KREX Protein Folding Technology
    • ORVAR Autoantigen Discovery Platform
    • The Value of Autoantibodies
    • Bioinformatics for Autoantibodies
  • Resources
    • Videos
    • Publications
    • Product Information
    • White Papers & Case Studies
    • Protein List
    • FAQ
  • About
    • Company Overview
      • Patents
    • Meet Our Team
    • News & Events
  • Menu Menu
  • Join Our Team
  • Contact

Publications

Review our scientific literature

Autoimmune Disease

Cancer

Infectious Disease

Neurological Disease

Other Diseases

Technology

Autoimmune Disease

Identification of Potential Autoantigens in Anti-CCP-positive and Anti-CCP-negative Rheumatoid Arthritis using Citrulline-specific Protein Arrays

Stensballe, Allan, Poulsen, Thomas B. G., et al. 2021. “Identification of Potential Autoantigens in Anti‑CCP‑positive and Anti‑CCP‑negative Rheumatoid Arthritis using Citrulline‑specific Protein Arrays.” Nature (2021) 11:17300 doi.org/10.1038/s41598-021-96675-z View Paper

Anti-TROVE2 Antibody Determined by Immune-Related Array May Serve as a Predictive Marker for Adalimumab Immunogenicity and Effectiveness in RA

Chen, Po-Ku, Joung-Liang Lan, Yi-Ming Chen, et al. 2021. “Anti-TROVE2 Antibody Determined by Immune-Related Array May Serve as a Predictive Marker for Adalimumab Immunogenicity and Effectiveness in RA.” Edited by Baohui Xu. Journal of Immunology Research 2021 (March): 1–13. doi:10.1155/2021/6656121 View Paper

Detection of Putative Autoantibodies in Systemic Lupus Erythematous using a Novel Native-Conformation Protein Microarray Platform

Mak, Anselm, Nien Yee Kow, Nur Hafiza Ismail, et al. 2020. “Detection of Putative Autoantibodies in Systemic Lupus Erythematous Using a Novel Native-Conformation Protein Microarray Platform.” Lupus 29 (14): 1948–54. doi:10.1177/0961203320959696 View Paper

Identification of Novel Native Autoantigens in Rheumatoid Arthritis

Poulsen, Thomas B. G., Dres Damgaard, Malene Møller Jørgensen, et al. 2020. “Identification of Novel Native Autoantigens in Rheumatoid Arthritis.” Biomedicines 8 (6): 141. doi:10.3390/biomedicines8060141 View Paper

Autoantibodies Targeting TLR and SMAD Pathways Define New Subgroups in Systemic Lupus Erythematosus

Lewis, Myles J., Michael B. McAndrew, Colin Wheeler, et al. 2018. “Autoantibodies Targeting TLR and SMAD Pathways Define New Subgroups in Systemic Lupus Erythematosus.” Journal of Autoimmunity 91 (July): 1–12. doi:10.1016/j.jaut.2018.02.009 View Paper

Cancer

A Highly Predictive Autoantibody-based Biomarker Panel for Prognosis in Early-stage NSCLC with Potential Therapeutic Implications

Akshay J. Patel, Ti-Myen Tan, Alex G. Richter, Babu Naidu, Jonathan M. Blackburn and Gary W. Middleton. 2021. “A Highly Predictive Autoantibody-based Biomarker Panel for Prognosis in Early-stage NSCLC with Potential Therapeutic Implications” British Journal of Cancer. doi: 10.1038/s41416-021-01572-x View Paper

B Cells and Antibody Production in Melanoma

Da Gama Duarte, Jessica, Janique M. Peyper, and Jonathan M. Blackburn. 2018. “B Cells and Antibody Production in Melanoma.” Mammalian Genome 29 (11): 790–805. doi:10.1007/s00335-018-9778-z View Paper

A Diagnostic Autoantibody Signature for Primary Cutaneous Melanoma

Zaenker, Pauline, Johnny Lo, Robert Pearce, et al. 2018. “A Diagnostic Autoantibody Signature for Primary Cutaneous Melanoma.” Oncotarget 9 (55): 30539–51. doi:10.18632/oncotarget.25669. View Paper

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma

Da Gama Duarte, Jessica, Sagun Parakh, Miles C. Andrews, et al. 2018. “Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin Followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.” Frontiers in Immunology 9. doi:10.3389/fimmu.2018.00411. View Paper

Novel Potential Serological Prostate Cancer Biomarkers Using CT100+ Cancer Antigen Microarray Platform in a Multi-Cultural South African Cohort

Adeola, Henry A., Muneerah Smith, Lisa Kaestner, et al. 2016. “Novel Potential Serological Prostate Cancer Biomarkers Using CT100+ Cancer Antigen Microarray Platform in a Multi-Cultural South African Cohort.” Oncotarget 7 (12): 13945–64. doi:10.18632/oncotarget.7359. View Paper

Development Of A Novel, Quantitative Protein Microarray Platform for the Multiplexed Serological Analysis of Autoantibodies to Cancer-Testis Antigens

Beeton-Kempen, Natasha, Jessica Duarte, Aubrey Shoko, et al. 2014. “Development of a Novel, Quantitative Protein Microarray Platform for the Multiplexed Serological Analysis of Autoantibodies to Cancer-Testis Antigens.” International Journal of Cancer 135 (8): 1842–51. doi:10.1002/ijc.28832. View Paper

Serologic Autoantibodies as Diagnostic Cancer Biomarkers — A Review

Zaenker, Pauline, and Melanie R. Ziman. 2013. “Serologic Autoantibodies as Diagnostic Cancer Biomarkers—A Review.” Cancer Epidemiology and Prevention Biomarkers 22 (12): 2161–81. doi:10.1158/1055-9965.EPI-13-0621. View Paper

Protein Function Microarrays: Design, Use and Bioinformatic Analysis in Cancer Biomarker Discovery and Quantitation

Duarte, Jessica, Jean-Michel Serufuri, Nicola Mulder, et al. 2013. “Protein Function Microarrays: Design, Use and Bioinformatic Analysis in Cancer Biomarker Discovery and Quantitation.” In Bioinformatics of Human Proteomics, edited by Xiangdong Wang, 39–74. Translational Bioinformatics. Dordrecht: Springer Netherlands. doi:10.1007/978-94-007-5811-7_3 View Paper

Seromic Analysis of Antibody Responses in Non-Small Cell Lung Cancer Patients and Healthy Donors Using Conformational Protein Arrays

Gnjatic, Sacha, Colin Wheeler, Martin Ebner, et al. 2009. “Seromic Analysis of Antibody Responses in Non-Small Cell Lung Cancer Patients and Healthy Donors Using Conformational Protein Arrays.” Journal of Immunological Methods 341 (1–2): 50–58. doi:10.1016/j.jim.2008.10.016 View Paper

Functional Protein Microarrays for Parallel Characterisation of P53 Mutants

Boutell, Jonathan M., Darren J. Hart, Benjamin L. J. Godber, et al. 2004. “Functional Protein Microarrays for Parallel Characterisation of P53 Mutants.” PROTEOMICS 4 (7): 1950–58. doi:https://doi.org/10.1002/pmic.200300722 View Paper

Infectious Disease

Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic

Michelle O. Mullins, Muneerah Smith, Hazel Maboreke, Andrew J. M. Nel, Ntobeko A. B. Ntusi, Wendy A. Burgers and Jonathan M. Blackburn. 2023.Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic. Viruses 2023,15,584. https://doi.org/ 10.3390/v15020584 View Paper

Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19

Muneerah Smith, Gaurav Kwatra, Alane Izu, Andrew Nel, Clare Cutland, Khatja Ahmed, Vicky Baillie, Shaun Barnabas, Qasim Bhorat , Carmen Briner, Erica Lazarus, Keertan Dheda, Lee Fairlie, Anthonet Koen, Shabir Madhi and Jonathan M. Blackburn. 2023. Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein View Paper

Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort

Smith, M.; Abdesselem, H.B.; Mullins, M.; Tan, T.-M.; Nel, A.J.M.; Al-Nesf, M.A.Y.; Bensmail, I.; Majbour, N.K.; Vaikath, N.N.; Naik, A.; et al. Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort. Viruses 2021, 13, 786. https://doi.org/10.3390/ v13050786 View Paper

Quantitative, Epitope-specific, Serological Screening of COVID-19 Patients Using a Novel Multiplexed Array-based Immunoassay Platform

Blackburn, Jonathan M, Nurdiana Anuar, Ti Myen Tan, et al. 2020. “Quantitative, Epitope-Specific, Serological Screening of COVID-19 Patients Using a Novel Multiplexed Array-Based Immunoassay Platform.” Preprint. Infectious Diseases (except HIV/AIDS). doi:10.1101/2020.09.25.20201269 View Paper

COVID-19 Antibody Testing: From Hype to Immunological Reality

Gray, C. M., J. Peter, M. Mendelson, et al. 2020. “COVID-19 Antibody Testing: From Hype to Immunological Reality.” South African Medical Journal 110 (9): 837–41 View Paper

Identifying Protein Biomarkers in Predicting Disease Severity of Dengue Virus Infection Using Immune-Related Protein Microarray

Soe, Hui, Yean Yong, Mazen M. Al-Obaidi, et al. 2018. “Identifying Protein Biomarkers in Predicting Disease Severity of Dengue Virus Infection Using Immune-Related Protein Microarray.” Medicine 97 (5). doi:10.1097/MD.0000000000009713 View Paper

Autoantibody Profile of Patients Infected with Knowlesi Malaria

Liew, Jonathan, Amirah Amir, Yeng Chen, et al. 2015. “Autoantibody Profile of Patients Infected with Knowlesi Malaria.” Clinica Chimica Acta; International Journal of Clinical Chemistry 448 (August): 33–38. doi:10.1016/j.cca.2015.06.006 View Paper

Neurological Disease

Identification of Novel Candidate Autoantibodies in Alzheimer’s Disease

B. Z. Wang, F. Z. Zailan, et al. 2020. “Identification of Novel Candidate Autoantibodies in Alzheimer’s Disease.” European Journal of Neurology 2020, 27: 2292–2296. doi:10.1111/ene.14290 View Paper

Augmentation of Autoantibodies by Helicobacter pylori in Parkinson’s Disease Patients May Be Linked to Greater Severity

Suwarnalata, Gunasekaran, Ai Huey Tan, Hidayah Isa, et al. 2016. “Augmentation of Autoantibodies by Helicobacter Pylori in Parkinson’s Disease Patients May Be Linked to Greater Severity.” PloS One 11 (4): e0153725. doi:10.1371/journal.pone.0153725 View Paper

Other Diseases

Novel Auto-antibodies in Idiopathic Small Fiber Neuropathy

Amanda CY Chan, Hiu Yi Wong, Yao Feng Chong, et al. 2021. “Novel Auto-antibodies in Idiopathic Small Fiber Neuropathy” Annals of Neurology doi: 10.1002/ana.26268 View Paper

Potential Novel Proteomic Biomarkers for Diagnosis of Vertebral Osteomyelitis Identified using an Immunomics Protein Array Technique

Chen, Chang-Hua, Ing-Lin Chang, Shu-Hui Wang, et al. 2020. “Potential Novel Proteomic Biomarkers for Diagnosis of Vertebral Osteomyelitis Identified Using an Immunomics Protein Array Technique: Two Cases Reports.” Medicine 99 (43): e22852. doi:10.1097/MD.0000000000022852 View Paper

A Novel Method to Identify Autoantibodies against Putative Target Proteins in Serum from Beta-Thalassemia Major: A Pilot Study

Sumera, Afshan, Nur Diana Anuar, Ammu Kutty Radhakrishnan, et al. 2020. “A Novel Method to Identify Autoantibodies against Putative Target Proteins in Serum from Beta-Thalassemia Major: A Pilot Study.” Biomedicines 8 (5): 97. doi:10.3390/biomedicines8050097 View Paper

Technology

Pro-MAP: A Robust Pipeline for the Pre-processing of Single Channel Protein Microarray Data

Metoboroghene Oluwaseyi Mowoe, Shaun Garnett, Katherine Lennard, Jade Talbot, Paul Townsend, Eduard Jonas and Jonathan Michael Blackburn. 2022. "Pro-MAP: A Robust Pipeline for the Pre-processing of Single Channel Protein Microarray Data." BMC Bioinformatics (2022) 23:534 https://doi.org/10.1186/s12859-022-05095-x View Paper

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation

Aziz, Farhanah, Muneera Smith, and Jonathan M Blackburn. 2019. “Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation.” In Autoantibodies and Cytokines, edited by Wahid Ali Khan. IntechOpen. doi:10.5772/intechopen.75200 View Paper

Applications of Functional Protein Arrays for Detection and Development of Autoantibody-based Diagnostics and Therapeutics

Aziz, Farhanah et al. 2018. “Applications of Functional Protein Arrays for Detection and Development of Autoantibody-based Diagnostics and Therapeutics.” International Biopharmaceutical Industry 1 (2). https://www.biopharmaceuticalmedia.com/applications-of-functional-protein-arrays-for-detection-and-development-of-autoantibody-based-diagnostic-and-therapeutic/ View Paper

Advances in the Development of Human Protein Microarrays

Duarte, Jessica G., and Jonathan M. Blackburn. 2017. “Advances in the Development of Human Protein Microarrays.” Expert Review of Proteomics 14 (7): 627–41. doi:10.1080/14789450.2017.1347042 View Paper

Protein Function Microarrays for Customised Systems-Oriented Proteome Analysis

Blackburn, Jonathan M., and Aubrey Shoko. 2011. “Protein Function Microarrays for Customised Systems-Oriented Proteome Analysis.” Methods in Molecular Biology (Clifton, N.J.) 785: 305–30. doi:10.1007/978-1-61779-286-1_21 View Paper

Seromic Analysis of Antibody Responses in Non-Small Cell Lung Cancer Patients and Healthy Donors Using Conformational Protein Arrays

Sacha Gnjatic, Colin Wheeler, Martin Ebner, Erika Ritter, Anne Murray, Nasser K.Altorki, Cathy A.Ferrara, Henry Hepburne-Scott, Sarah Joyce, Jens Koopman, Michael B.McAndrew, Nicholas Workman, Gerd Ritter, Rachel Fallon, Lloyd J.Old. 2009. “Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.” Journal View Paper

Ready to accelerate your program?

Let’s discuss your needs
  • Services
  • Applications
  • Technology
  • Resources
  • About

Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction and development of companion diagnostics.

Copyright 2008 – 2022 Sengenics All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D

Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy

Design and development by RainCastle Communications.

This site uses cookies. By continuing to use this site, you accept our use of cookies. Learn more about our Privacy Statement and Cookie Policy here.

I Accept

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Accept settingsHide notification only

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Download the White Paper

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

"*" Indicates required fields

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation


Read the Review

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.